More Talk, Less Action Could Be Good for Credit Markets

More Talk, Less Action Could Be Good for Credit Markets

Our Head of Corporate Credit Research lists realistic scenarios for why credit could outperform expectations in 2025, despite some risks posed by policy changes from the incoming administration.


----- Transcript -----


Welcome to Thoughts on the Market. I'm Andrew Sheets, head of Corporate Credit Research at Morgan Stanley. Today I’ll be discussing realistic scenarios where things could be better than we expect.

It's Friday December 20th at 2pm in London.

Credit is an asset class that always faces more limited upside, and the low starting point for spreads as we enter 2025 further limits potential gains. Nevertheless, there are still a number of ways where this market could do better than expected, with spreads tighter than expected, into next year.

An obvious place to start is U.S. policy. Morgan Stanley’s public policy strategy team thinks the incoming administration will be a story of “fast announcement, slow implementation”, with the growth and inflation impact of tariffs and immigration falling more in 2026 (rather than say earlier). And so if one looks at Morgan Stanley’s forecasts, our growth numbers for 2025 are good, our 2026 numbers are weaker.

The bull case could be that we see more talk but less ultimate action. Scenarios where tariffs are more of a negotiating tool than a sustained policy would likely mean less change to the current (credit friendly) status quo, and also increase the likelihood that the Federal Reserve will be able to lower interest rates even as growth holds up. Rate cuts with good growth is a rare occurrence, but when you do get it, it can be extremely good. If one thinks of the mid-1990s, another time where we had this combination, credit spreads were even tighter than current levels. Another path to the bull case is better funding conditions in the market. Some loosening of bank capital requirements or stronger demand for collateralized loan obligations could both flow through to tighter spreads for the assets that these fund, especially things like leveraged loans. If we think back to periods where credit spreads were tighter than today, easier funding was often a part of the story.

Now, a more aggressive phase of corporate activity could be a risk to credit, but M&A can also be a positive event, especially on a name by name basis. If merger and acquisition activity becomes a story of, say, larger companies buying smaller ones, that could mean that weaker, high yield credits get absorbed by larger, stronger, investment grade balance sheets. And so for those high yield bonds or loans, this can be an outstanding outcome. Another way things could be better than expected for credit is that growth in Europe and China is better than expected. In speaking with investors over the last few weeks, I think it's safe to say that expectations for both regions are pretty low. And so if things are better than these low expectations, spreads, especially in Europe, which are not as tight as those in the U.S., could go tighter.

But the most powerful form of the credit bull case might be the simplest. Morgan Stanley expects the Federal Reserve, the Bank of England, and the European Central Bank to all lower interest rates much more than markets expect next year, even as, for the most part, growth in 2025 holds up. Due in a large part to those expected rate cuts, we also think the yields fall more than expected. If that's right, credit could quietly have an outstanding year for total return, which is boosted as yields fall. Indeed, on our forecast, U.S. investment grade credit, a relatively sleepy asset class, would see a total return of roughly 10%, higher than our expected total return for the mighty S&P 500. Not all credit investors care about total return. But for those that do, that outcome could feel very bullish.

Thanks for listening. If you enjoy the show, leave us a review wherever you listen, and share Thoughts on the Market with a friend or colleague today.

Jaksot(1569)

The Economic Stakes of President Trump’s Immigration Policy

The Economic Stakes of President Trump’s Immigration Policy

Our economists Michael Gapen and Sam Coffin discuss how a drop in immigration is tightening labor markets, and what that means for the U.S. economic outlook and Fed policy. Read more insights from Mor...

13 Kesä 202510min

Midyear Credit Outlook: Slowdown in Europe

Midyear Credit Outlook: Slowdown in Europe

Our analysts Andrew Sheets and Aron Becker explain why European credit markets’ performance for the rest of 2025 could be tied to U.S. growth.Read more insights from Morgan Stanley.----- Transcript --...

12 Kesä 20259min

What the New Tax Bill Means for Cross-Border Portfolios

What the New Tax Bill Means for Cross-Border Portfolios

Our Global Head of Fixed Income Research and Public Policy Strategy Michael Zezas reads the fine print of U.S. tax legislation to understand how it might affect foreign companies operating in the U.S....

11 Kesä 20253min

How China Is Rewriting the AI Code

How China Is Rewriting the AI Code

Our Head of Asia Technology Research Shawn Kim discusses China's distinctly different approach to AI development and its investment implications.Read more insights from Morgan Stanley.----- Transcript...

10 Kesä 20253min

U.S. Financials Conference: Three Key Themes to Watch

U.S. Financials Conference: Three Key Themes to Watch

Our analysts Betsy Graseck, Manan Gosalia and Ryan Kenny discuss the major discussions they expect to highlight Morgan Stanley’s upcoming U.S. Financials conference.Read more insights from Morgan Stan...

9 Kesä 202510min

Standing by Our Outlook

Standing by Our Outlook

Morgan Stanley’s midyear outlook defied the conventional view in a number of ways. Our analysts Serena Tang and Vishy Tirupattur push back on the pushback to their conclusions, explaining the thought ...

6 Kesä 20259min

5 Reasons the Obesity Drug Market Remains Strong

5 Reasons the Obesity Drug Market Remains Strong

The global market for obesity drugs is expanding. Our U.S. Pharma and Biotech Analyst Terrence Flynn discusses what’s driving the next stage of global growth for GLP-1 medicines.Read more insights fro...

5 Kesä 20253min

Midyear U.S. Credit Outlook: Why Investors Should Be Selective

Midyear U.S. Credit Outlook: Why Investors Should Be Selective

Our analysts Andrew Sheets and Vishwas Patkar take stock of the U.S. credit market, noting which segments are on firm footing going into a period of slower growth.Read more insights from Morgan Stanle...

4 Kesä 20257min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
pomojen-suusta
ostan-asuntoja-podcast
rss-rahamania
rahapuhetta
rss-myyntikoulu
rss-draivi
herrasmieshakkerit
juristipodi
salkunrakentaja-podi
sijoitusovi-podcast
rss-h-asselmoilanen
rss-lahtijat
rss-startup-ministerio
rss-seuraava-potilas
rss-set-for-life-sijoita-ja-vaurastu
rss-viisas-raha-podi